High-dose abciximab during coronary angioplasty in a patient with essential thrombocytosis

Journal of Invasive Cardiology

Volumn 10, Issue 3, 1998, Pages 173-176

  Kohl, David W ^a  

^a Bay Area Heart Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001671321     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Tcheng J, Ellis SG, George BS, et. al. Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high risk coronary angioplasty. Circulation 1994;90:757-764.